Immunohistochemical Expression of p53 in Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma.
Context. Immunohistochemical stains for p53 are used as a diagnostic marker associated with malignancy in several histologic types of salivary gland tumors. This marker may be useful in differentiating pleomorphic adenoma (PA) from carcinoma ex pleomorphic adenoma (CPA), as these tumors are often difficult to distinguish on the basis of morphology alone. Objective. to evaluate whatever inactivation of tumor suppressor gene (p53) increases with the tumor progression from normal salivary tissue to PA and eventually CPA. Design. Paraffin blocks of 29 cases of PA, which were surrounded by normal parotid gland, and 27 cases of carcinoma ex pleomorphic adenoma were retrieved and validated. In all cases of carcinoma ex pleomorphic adenoma, a PA "ghost" was identified, and the malignant element was either undifferentiated carcinoma or adenocarcinoma. Results. The results showed negative nuclear expression of P53 in normal parotid gland. Nuclear P53 was expressed strongly in 6/29 (20.7%) pleomorphic salivary adenoma and 10/27 (37%) carcinoma ex pleomorphic adenoma. Conclusion. Our data suggest that inactivation of p53 may play an important role in the evolution of pleomorphic salivary adenoma and carcinoma ex pleomorphic adenoma.
Department of Oral Pathology, Faculty of Dentistry, University of Aleppo, Aleppo, Syria.
Bassel
B
Tarakji
Omar
O
Kujan
Mohammad Z
MZ
Nassani
Cancer. 1981 Jul 1;48(1):113-21
6263450
Oncol Rep. 1999 May-Jun;6(3):539-45
10203588
Nature. 1989 Dec 7;342(6250):705-8
2531845
Diagn Mol Pathol. 1998 Aug;7(4):224-31
9917133
Pathol Int. 1998 Apr;48(4):265-72
9648154
Int J Oncol. 2000 Mar;16(3):477-83
10675478
Cancer Lett. 1992 Jul 31;65(1):61-71
1324786
Br J Cancer. 1996 Mar;73(6):728-34
8611372
Anal Quant Cytol Histol. 1999 Aug;21(4):336-42
10560511
J Oral Pathol Med. 1997 May;26(5):217-23
9178173
Cancer. 1995 Apr 15;75(8):2037-44
7697591
J Immunol Methods. 1992 Jul 6;151(1-2):237-44
1378473
World J Surg Oncol. 2010 Mar 30;8:24
20353573
J Pathol. 1992 Apr;166(4):389-94
1381431
Hum Pathol. 1996 Aug;27(8):782-6
8760010
J Pathol. 1997 Jun;182(2):180-4
9274528
Int J Cancer. 1997 Nov 27;73(5):639-44
9398039
Hum Pathol. 2009 Mar;40(3):390-7
18992915
Cancer. 1997 Jun 15;79(12):2314-9
9191518
Virchows Arch A Pathol Anat Histopathol. 1992;421(5):415-20
1333678
Acta Pathol Jpn. 1993 Jul-Aug;43(7-8):413-22
8396843
Gan To Kagaku Ryoho. 2004 Mar;31(3):314-7
15045931
Eur Rev Med Pharmacol Sci. 2008 Sep-Oct;12(5):321-5
19024217